Dysprosium-enhanced MR imaging for tumor tissue characterization. An experimental study in a human xenograft model

Acta Radiol. 1997 Mar;38(2):281-6. doi: 10.1080/02841859709172064.

Abstract

Purpose: To evaluate dysprosium-enhanced MR imaging for differentiation between morphologically intact and necrotic tumor tissue in a tumor model.

Material and methods: A human colon carcinoma was transplanted subcutaneously into 9 nude (immunodeprived) rats. MR imaging was performed before and after injection of the dysprosium agent Dy-DTPA-BMA. T1-, T2- and T2*-weighted sequences were acquired. The tumors were dissected, histological sections were prepared, and compared with corresponding MR images.

Results: In intact tissue, the MR signal intensity in the T2- and T2*-weighted images decreased after Dy injection and the delineation of the intact regions were sharp and corresponded well to the gross histological sections.

Conclusion: Dy-enhanced MR imaging facilitated the differentiation between intact and necrotic tumor tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / diagnosis
  • Animals
  • Colonic Neoplasms / diagnosis*
  • Contrast Media
  • Dysprosium*
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Male
  • Necrosis
  • Neoplasm Transplantation
  • Rats
  • Rats, Nude
  • Transplantation, Heterologous

Substances

  • Contrast Media
  • Dysprosium